Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
09/2007
09/12/2007EP1830840A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
09/12/2007EP1664059B1 Thienopyrroles as antiviral agents
09/12/2007CN101033232A Method of preparing olanzapine crystal system I
09/11/2007US7268220 Chelation compounds, radionuclide metal chelate compounds (i.e., complexes) and radiolabeled targeting moieties (i.e., conjugates) formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic purposes
09/11/2007US7268158 6H-THIENO [2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH)
09/11/2007US7268143 Isoquinoline derivatives and methods of use thereof
09/11/2007US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/07/2007WO2007100061A1 Fluorescent probe
09/07/2007CA2638734A1 Inhibitors of the unfolded protein response and methods for their use
09/06/2007US20070208166 Tao Kinase Modulators And Method Of Use
09/06/2007US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
09/06/2007US20070208003 Compounds and methods for treating dyslipidemia
09/06/2007DE112005000641T5 Neues Verfahren zur Herstellung einer pharmazeutisch reinen polymorphen Form I von Olanzapin New process for the preparation of a pharmaceutically pure polymorphic form I of olanzapine
09/05/2007EP1829543A1 Preventive agent/remedial agent for constipation predominant IBS
09/05/2007EP1828200A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease.
09/05/2007EP1828199A1 Thieno-pyridine derivatives as gaba-b allosteric enhancers
09/05/2007EP1828198A1 Method for separating of optically pure thiophene compounds using simulated moving bed chromatography
09/05/2007EP1828197A1 NOVEL SUBSTITUTED THIOPHENEPYRIMIDINONE DERIVATIVES AS INHIBITORS OF 17ß-HYDROXYSTEROID DEHYDROGENASE
09/05/2007EP1463733B1 Mitotic kinesin inhibitors
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007CN101031570A Inhibitors of vegf receptor and hgf receptor signaling
09/05/2007CN101031567A Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
09/05/2007CN100335484C Method for preparing neutral polyethyidenedioxythiophene and its correspondent compound
09/04/2007US7265128 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
09/04/2007CA2271861C Heterocyclic metallocenes and polymerization catalysts
08/2007
08/30/2007WO2007098356A1 Congeners of milnacipran as monoamine re-uptake
08/30/2007WO2007097395A1 Fluorine-containing compound and method for producing same, fluorine-containing polymer, organic thin film, and organic thin film device
08/30/2007WO2007096895A1 Preparation of anhydrous olanzapine of form-1
08/30/2007WO2007096150A2 Organic compounds
08/30/2007WO2007076228A3 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
08/30/2007WO2007050726A3 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
08/30/2007WO2007042912A3 Heterocyclic compounds as pstat3/il-6 inhibitors
08/30/2007US20070203101 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
08/30/2007CA2640488A1 Aza-thia-benzoazulene analgesics
08/29/2007EP1824860A2 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof
08/29/2007EP1824859A1 Substituted thieno[2,3-c]pyrazoles, method for the preparation thereof, compositions containing them and use thereof
08/29/2007EP1824821A2 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
08/29/2007EP1824482A1 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
08/29/2007EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia
08/29/2007CN101027308A Photochromic monomers, photochromic polymers based on the same, photochromic recording media comprising the photochromic polymers, and 3D read/write optical memory comprising the recording media
08/29/2007CN101027305A Fused heterocyclic kinase inhibitors
08/29/2007CN101024627A Nitrogen-containing aromatic derivatives
08/29/2007CN100334093C Thienopyrimidinediones and their use in the modulation of autoimmune disease
08/29/2007CN100334092C Process for producing cyclic thioether and synthetic intermediate thereof
08/29/2007CN100334086C Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives
08/28/2007US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1
08/23/2007WO2007095628A1 Pyrazoloquinolones are potent parp inhibitors
08/23/2007WO2007094006A1 Process for preparation of clopidogrel bisulfate form 1
08/23/2007WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/23/2007WO2007093363A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
08/23/2007WO2007076085A3 Fused pyrimidones and thiopyrimidones, and uses thereof
08/23/2007WO2007059257A3 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
08/23/2007WO2007029096A3 Novel polymorphic forms of clopidogrel hydrochloride
08/23/2007WO2007015866A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders
08/23/2007US20070197789 Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein
08/23/2007US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome
08/23/2007US20070197536 Pyridazin-3(2)-one derivatives and their use as pde4 inhibitors
08/23/2007US20070197527 Bicyclic heteroaromatic compounds
08/23/2007US20070197499 Pharmaceutical compounds
08/23/2007US20070197393 Tricyclic benzoylpyrazole derivatives
08/23/2007US20070196903 Overcoming DAPA aminotransferase bottlenecks in biotin vitamers biosynthesis
08/23/2007CA2641776A1 Pyrazoloquinolones are potent parp inhibitors
08/23/2007CA2636873A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/23/2007CA2636605A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
08/22/2007EP1819719A2 Oligonucleotide probes
08/22/2007EP1819712A1 New pyridothienopyrimidine derivatives
08/22/2007EP1819711A2 Pyrimidothienoindazoles capable of inhibiting tyrosine kinases of the epidermal growth factor
08/22/2007EP1819710A1 New pyridothienopyrimidine derivatives
08/22/2007EP1648904B1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands
08/22/2007CN1332950C Improved compounds for generating chemiluminescence with peroxidase
08/22/2007CN101023085A Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors
08/21/2007US7259168 2-Aminoalkyl-thieno[2,3-d]pyrimidines
08/16/2007WO2006079637A8 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
08/16/2007WO2005120186A3 Methyl 2,4,9-trithiaadamantane-7-carboxylate
08/16/2007US20070191608 intermediates for p38 MAP kinase inhibitors; industrial scale; 3-cyano-6-oxo-2-thio-1,6-dihydropyridines or pyrimidine, 2,4-diones as starting reactants and 2-cyano-N-phenylthioacetamide; cyclization; diazotization of 3-amino-7H-thieno[2,3-b]pyridin-6-ones, halide displacement
08/16/2007US20070191469 Novel tetracyclic tetrahydrofuran derivatives
08/16/2007US20070191348 Isopropanol water solvate of olanzapine
08/16/2007US20070191337 Annellated carbamyl-aza-heterocyclic compounds, a focused library, pharmaceutical compositions, and methods of preparing the same
08/15/2007EP1817313A1 Process for pd-catalysed c-n coupling in specific solvent systems
08/15/2007EP1817310A1 (spirocyclylamido) aminothiophene compounds as c-kit proto-oncogene inhibitors
08/15/2007EP1817000A1 Thienopyrimidines as cooling agents
08/15/2007EP1490371B1 Thiophene-based tricyclic compounds and pharmaceutical compositions comprising same
08/15/2007CN101018801A Method for labeling and purifying nucleic acids of interest present in a biological sample to be treated in a single reaction vessel
08/14/2007US7256158 Animal husbandry; veterinary medicine
08/14/2007CA2251016C .alpha.1-adrenergic receptor antagonists
08/14/2007CA2223414C Heteroaryl diol acids as leukotriene antagonists
08/09/2007WO2007089512A1 Glucokinase activators
08/09/2007WO2007088345A1 Thieno-pyridine derivatives as mek inhibitors
08/09/2007WO2007088063A1 Acid addition salts of n-{3-[4-(2-methoxyphenyl)-l-piperazinyl]-propyl}-7-oxo-5- trifluoromethyl-7h-thieno[3,2-b]pyran-3-carboxamide
08/09/2007US20070185185 Derivatives of thienopyrrole as gnrh antagonists
08/09/2007US20070185131 Heterocyclic Compounds
08/09/2007US20070185129 Acid addition salts of thienopyrancarboxamide derivatives
08/09/2007US20070185120 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis
08/09/2007US20070185089 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
08/09/2007US20070185087 Compounds and methods for inhibiting mitotic progression
08/09/2007CA2640594A1 Thieno-pyridine derivatives as mek inhibitors
08/09/2007CA2637172A1 Pyridin-2-amine derivatives and their use as glucokinase activators
08/08/2007EP1814908A1 Activated labeling reagents and methods for preparing and using the same
08/08/2007EP1814886A1 A process for the preparation of n-demethylolanzapine
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 214